Antidepressants and
Breastfeeding
July 6, 2001 (HealthScout) Thirty weeks into
her pregnancy with her second child, Dede Adams of Atlanta, Ga., knew
something was wrong.
"I became very anxious, and I'm not an anxious
person," she said. "I had an overwhelming fear that something was wrong."
Adams was fortunate. She was referred by a
friend to the pregnancy and
postpartum mood disorders clinic at Emory University. There, psychiatrist
Zachary Stowe, MD, an associate professor of psychiatry and
obstetrics-gynecology, informed Adams that her anxiety could be a symptom of
an underlying depression and possible early evidence of
postpartum depression.
Postpartum depression involves moderate to
severe depression beginning slowly and sometimes undetectably during the
second to third week after delivery, and afflicts an estimated 10% of pregnant
women.
On Stowe's recommendation, Adams began to take
the
antidepressant Paxil. The results were profound: Within weeks she was back
to normal. She continued using the medication after her son William was born,
and -- against the recommendation of her pediatrician -- throughout the year
and a half she was breastfeeding William.
Today, both Adams and William, now 4 years
old, are healthy, with no discernible ill effects from exposure to
antidepressant medication through breast milk. But the dilemma faced by Adams
is one that confronts many thousands of moms being treated with depression:
Treat the depression and forgo breastfeeding, or decline depression treatment
in favor of the nurturing and nutritional benefits of breastfeeding.
Yet some psychiatrists, including Stowe, say
that in most cases there should be no dilemma.
"We know more about antidepressants and breast
milk than we know about any other class of medication in the world," Stowe
says. "We have studied them extensively because we were afraid of them, but we
have not found any pattern of consistent adverse problems associated with
antidepressant use and breastfeeding."
Stowe says that exposure to medication that
crosses the placenta prior to delivery is liable to be greater than any
exposure through breast milk. "We see a lot of people taking antidepressant
medication during pregnancy and being told they can't breastfeed," says Stowe.
"It's the dumbest thing I've ever heard of."
Nevertheless, "trace elements" of medication
can be found in the blood of breastfed infants, and may vary according to the
medication and the disorder that is being treated. And because there have been
isolated reports of adverse events in breastfed infants that may be related to
maternal antidepressant use, the decision remains clouded by a degree of
scientific ambiguity.
A recent report in the American Journal of
Psychiatry -- of which Stowe was a co-author -- suggests that decisions
about using psychiatric medications while breastfeeding should be made on a
case-by-case basis. And that decision should be made in the context of a range
of factors, including not only information about possible side effects, but
also consideration of the mother's commitment to breastfeeding.
"There are clear benefits to breastfeeding,"
according to Stowe. "If it's important to the woman, it should be their
decision."
The study involved an extensive search of
medical literature for reports on a wide range of medications used during
breastfeeding. That search yielded none of the preferred controlled trials on
the subject -- the kind of trials comparing adverse events in infants among
mothers who used psychiatric medications during breastfeeding, and those who
did not. What exists, instead, is a substantial body of smaller "case series"
studies; these are published reports of patients who have used medication
during breastfeeding.
Among the findings from the literature review
was one showing 11 published reports of mothers using Prozac, involving 190
breastfed infants. Measurements of trace elements in infant blood varied, and
no negative effects were noted in 180 of the 190 infants.
One case of an infant was reported in which blood levels of medication in
the child were comparable to those in the mother. Negative effects included
excessive crying, decreased sleep, vomiting, and diarrhea, which dissipated
after discontinuation of breastfeeding.
Because of such reports, the authors of the
study recommend that infants being breastfed by moms on antidepressant
medication be actively monitored by a pediatrician.
But on that point, not all experts agree.
Psychiatrist Nada Stotland, MD, says that
while trace elements are sometimes found, it would be all but impossible for a
doctor to determine if they are related to any adverse events. And though she
supports the authors' conclusions that decisions should be made on a
case-by-case basis involving a host of factors, she is critical of the
recommendation that pediatricians actively monitor infants.
"That suggestion is very likely to intensify
the anxiety and guilt that many of these mothers experience as a part of their
depression," she says. Stotland is a professor of psychiatry and obstetrics
and gynecology at Rush Medical College in Chicago.
Resolution of the ambiguity around
breastfeeding while on psychiatric medication would appear to await greater
scientific understanding of the importance of trace elements and their
connection to infant behavior.
But for Dede Adams, there was little ambiguity
about her determination to breastfeed while she was still taking medication to
treat her depression. "I feel very strongly about breastfeeding," says Adams.
"It was something I wanted to do. Breastfeeding is such an incredible bond.
It's a sit-still time when you can just focus on your baby."
A note from Shani: Suffice to say it seems to be inconclusive for
infants, therefore it would
not be viewed as harmful to adults. Please keep in mind this is
only my opinion on the matter.